Amphista Lands Megadeals to Smash Cancer using Protein Degradation
As big pharma companies flock to drugs that destroy harmful proteins, the UK protein degradation…
As big pharma companies flock to drugs that destroy harmful proteins, the UK protein degradation…
The UK firm Artios Pharma raised a huge Series C round last week in one…
Advancing a drug to market readiness is a major milestone. After successfully completing clinical studies,…
Tech transfer appears on the agenda of almost every biotech company. After identifying a suitable…
Bioburden detection is one of the quality control measures required to ensure drug safety –…
By 2027, the global gene therapy market is estimated to reach a staggering value of…
By 2021, the global biologics market is expected to reach a value of $319B. But…
By 2024, the gene therapy market is expected to reach an estimated worth of $13B…
iOnctura, a spinout from Merck KGaA, has raised €15M to take its cancer and fibrosis…
An international collaboration called BioRescue has taken a step forward in bringing back the Northern…
Update (20/12/2019): After getting conditional approval in Europe in November, Merck has received FDA approval…
Merck will pay the microbiome company 4D Pharma up to €316.5M to develop vaccines based…